Context Therapeutics (CNTX) Shareholder's Equity (2020 - 2026)
Context Therapeutics (CNTX) Shareholder's Equity (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
502.95 Mn |
| 10 |
Context Therapeutics |
166.57 Mn |
166.57 Mn |
- |
52.20 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
52.20 Mn |
| Dec 31, 2025 |
60.47 Mn |
| Sep 30, 2025 |
73.17 Mn |
| Jun 30, 2025 |
82.54 Mn |
| Mar 31, 2025 |
90.98 Mn |
| Dec 31, 2024 |
95.27 Mn |
| Sep 30, 2024 |
83.86 Mn |
| Jun 30, 2024 |
101.10 Mn |
| Mar 31, 2024 |
8.44 Mn |
| Dec 31, 2023 |
11.87 Mn |
| Sep 30, 2023 |
18.38 Mn |
| Jun 30, 2023 |
24.00 Mn |
| Mar 31, 2023 |
28.73 Mn |
| Dec 31, 2022 |
34.76 Mn |
| Sep 30, 2022 |
38.07 Mn |
| Jun 30, 2022 |
41.65 Mn |
| Mar 31, 2022 |
45.39 Mn |
| Dec 31, 2021 |
48.27 Mn |
| Sep 30, 2021 |
-23.21 Mn |
| Jun 30, 2021 |
-22.30 Mn |
